drugset / Trial / NCT00143455
Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the effects of irinotecan hydrochloride with cisplatin to the "standard" regimen etoposide plus cisplatin on overall survival, in chemotherapy-naive patients with newly diagnosed Extensive Disease-Small Cell Lung Cancer (ED-SCLC).
Timeline
- Start
- 2002-06
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etoposide | Small molecule | 100 mg/m2 | — |
| Subject | Irinotecan | Small molecule | 65 mg/m2 | — |
| Background | Cisplatin | Other / unclassified | 80 mg/m2 | — |